SAFETY QUESTION: Public Citizen says it’s filed a federal lawsuit to force the Food and Drug Administration to remove the highest dose of an Alzheimer’s disease drug from the market over potentially fatal side effects.
DANGEROUS DELAY: The consumer group petitioned FDA in spring 2011 to remove from the market the 23-milligram dose of Aricept, saying it’s much riskier than two lower doses. Complications include vomiting, which can result in pneumonia and death.
THE RESPONSES: FDA won’t discuss the lawsuit, but says it’s doing an extensive analysis of the case. Aricept maker Eisai isn’t commenting either.
sponsored According to two 2015 surveys, 62 percent of Americans do not have enough savings to handle an unexpected emergency, much less any long-term plans.